Pflüger publishes observation study report on Otofren
German homeopathic laboratory Pflüger has released a report from an observation study on the use of its Otofren® preparation for middle ear inflammation.
Homeopathic Laboratory Alexander Pflüger GmbH & Co. KG has published a new report detailing its observation study on the efficacy and safety of its Otofren® preparation in treating middle ear inflammation.
The report is based on data collected from a prospective observation study that monitored patient responses and potential side effects during treatment. The aim was to gather further clinical insights into the preparation's real-world application.
Otofren® is a homeopathic medicine traditionally used to alleviate symptoms associated with ear pain and inflammation. The company stated that the study's findings support the preparation's role as a therapeutic option.
Pflüger is a German pharmaceutical company specializing in homeopathic and anthroposophic medicines. The company emphasizes the importance of research and quality control in its product development.